Strategic Investing
Numbers only tell half the story. Our strategic investing approach demands going further to get the full story.
As a leading global active asset manager, at T. Rowe Price we believe our clients’ portfolios are too important to be on autopilot. That is why our over 600 investment professionals conduct rigorous research to uncover opportunities for clients, going beyond the numbers by extracting forward-looking insights. Backed by the deep experience of our investment teams and the prudent risk management frameworks we apply, we call our investment approach strategic investing, and it’s aimed at delivering long-term success for clients’ portfolios.
Latest Articles

May 2022 / MARKETS & ECONOMY

No, We Are Not About to Return to 1970s-Style Inflation

No, We Are Not About to Return to 1970s-Style Inflation

No, We Are Not About to Return to 1970s-Style...

Today’s central banks are willing and able to tackle the problem

By Nikolaj Schmidt

Nikolaj Schmidt Chief International Economist

April 2022 / ASSET ALLOCATION VIEWPOINT

Economic Risks Are Rising

Economic Risks Are Rising

Economic Risks Are Rising

High inflation and economic weakness could stifle global economy.

By Tim Murray

Tim Murray Capital Markets Analyst

April 2022 / MARKETS & ECONOMY

Most Central Banks Have No Choice But to Remain Hawkish

Most Central Banks Have No Choice But to Remain Hawkish

Most Central Banks Have No Choice But to...

Few have the scope to loosen policy if economic conditions worsen

By Nikolaj Schmidt

Nikolaj Schmidt Chief International Economist

March 2022 / MARKETS & ECONOMY

The Fed Embarks on a Hiking Campaign to Counter Inflation

The Fed Embarks on a Hiking Campaign to Counter Inflation

The Fed Embarks on a Hiking Campaign to Counter...

High commodity prices, geopolitical risks complicate the Fed’s path

By Blerina Uruçi

Blerina Uruçi US Economist

January 2022 / BLOG

In With a Whimper, Out With a Bang

In With a Whimper, Out With a Bang

In With a Whimper, Out With a Bang

The investment story of 2022 will be tactical bear, structural bull

By Nikolaj Schmidt

Nikolaj Schmidt Chief International Economist

December 2021 / MARKETS & ECONOMY

China Remains Compelling Despite Regulatory Upheavals

China Remains Compelling Despite Regulatory Upheavals

China Remains Compelling Despite Regulatory...

Understanding the government’s social agenda is key

By Chris Kushlis & Justin Thomson

By Chris Kushlis & Justin Thomson

October 2021 / BLOG

Volatility Looms as Support Is Withdrawn

Volatility Looms as Support Is Withdrawn

Volatility Looms as Support Is Withdrawn

The supportive business cycle will likely provide opportunities, however

By Nikolaj Schmidt

Nikolaj Schmidt Chief International Economist

November 2021 / MARKET OUTLOOK

Growth Delayed but Not Derailed

Growth Delayed but Not Derailed

Growth Delayed but Not Derailed

Opportunities still lie ahead for firms and investors

By Robert W. Sharps

Robert W. Sharps Head of Investments, Group Chief Investment Officer

September 2021 / MARKETS & ECONOMY

Germany’s New Government Is Likely to Rewrite Economic Policy

Germany’s New Government Is Likely to Rewrite Economic Policy

Germany’s New Government Is Likely to Rewrite...

There will be a focus on green fiscal policy and redistribution

By Tomasz Wieladek

Tomasz Wieladek T.Rowe Price International Economist

July 2021 / MARKETS & ECONOMY

Central Bank Digital Currencies May Bring “Helicopter Money” Closer

Central Bank Digital Currencies May Bring “Helicopter Money” Closer

Central Bank Digital Currencies May Bring...

More efficient money transfers will likely bring down rates

By Tomasz Wieladek & Aadish Kumar

By Tomasz Wieladek & Aadish Kumar

Our Results

The long-term benefits of our strategic investing approach: a recent study shows that the rigor of our independent research and the decision-making of our experienced portfolio managers has created value over the long term.

Insights Archive

Innovating in health sciences by investing in breakthrough therapies

Portfolio manager Ziad Bakri visits biotech labs in a quest for the best investing ideas - like a firm that engineers a patient’s own cells to fight cancer.

Our Analysis

See how our analysts go beyond the numbers to identify growth opportunities and mitigate risks, in an array of countries, sectors and specialisms.

Analyst Video of the Month

Shopping for potential in Latin America and discovering e-commerce companies positioned for growth.

Equity analyst Paulina Amieva talks to management, suppliers, and customers in Mexico City to get a true sense of companies actively solving friction points that impede growth.

IMPORTANT INFORMATION

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.  

It is not intended for distribution to retail investors in any jurisdiction.